References to the "Company," "us," "our" or "we" refer to Arogo Capital
Acquisition Corp. The following discussion and analysis of our financial
condition and results of operations should be read in conjunction with our
audited financial statements and related notes included herein.
Cautionary Note Regarding Forward-Looking Statements
All statements other than statements of historical fact included in this Report
including, without limitation, statements under this "Management's Discussion
and Analysis of Financial Condition and Results of Operations" regarding our
financial position, business strategy and the plans and objectives of management
for future operations, are forward- looking statements. When used in this
Report, words such as "anticipate," "believe," "estimate," "expect," "intend"
and similar expressions, as they relate to us or our management, identify
forward-looking statements. Such forward-looking statements are based on the
beliefs of management, as well as assumptions made by, and information currently
available to, the Company's management. Actual results could differ materially
from those contemplated by the forward- looking statements as a result of
certain factors detailed in our filings with the SEC. All subsequent written or
oral forward-looking statements attributable to us or persons acting on our
behalf are qualified in their entirety by this paragraph.
The following discussion and analysis of our financial condition and results of
operations should be read in conjunction with the financial statements and the
notes thereto contained elsewhere in this Report. Certain information contained
in the discussion and analysis set forth below includes forward-looking
statements that involve risks and uncertainties.
Overview
We are a blank check company incorporated in June 2021 as a Delaware corporation
whose business purpose is to effect a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business combination with
one or more businesses, which we refer to as our initial business combination.
Our Sponsor is Koo Dom Investment LLC, a Delaware limited liability company. On
June 30, 2021, our Sponsor purchased 2,875,000 founder shares for an aggregate
purchase price of $25,000, or approximately $0.009 per share. On October 11,
2021, our sponsor surrendered 287,500 founder shares to the Company for
cancellation.
On December 29, 2021, we completed our initial public offering (the "Offering")
of 10,350,000 units ("Units"), including the issuance of 1,350,000 Units as a
result of the underwriter's full exercise of its over-allotment option. Each
Unit consists of one share of Class A common stock, par value $0.0001 per share
("Class A Common Stock"), and one redeemable warrant ("Warrant"), each whole
Warrant entitling the holder thereof to purchase one share of Class A Common
Stock at an exercise price of $11.50 per share, subject to adjustment, pursuant
to the Company's registration statement on Form S-1 (File Nos. 333-259338). The
Units were sold at an offering price of $10.00 per Unit, generating gross
proceeds of $103,500,000.
On December 29, 2021, simultaneously with the consummation of the Offering, the
Company completed a private placement of an aggregate of 466,150 units (the
"Private Placement Units") at a price of $10.00 per Private Placement Unit,
generating total gross proceeds of $4,661,500 (the "Private Placement"). A total
of $105,052,500, comprised of the proceeds from the Offering and the proceeds of
the Private Placement, net of the underwriting commissions, discounts, and
offering expenses, was deposited in a trust account established for the benefit
of the Company's public stockholders.
On February 11, 2022, the Class A Common Stock and Public Warrant included in
the Units began separate trading.
24
Charter Amendment Regarding Extension and Share Redemptions
At the March 24, 2023, Shareholders Meeting, our shareholders approved an
amendment to the Amended and Restated Certificate of Incorporation of the
Company (the "Charter Amendment"), and the Company subsequently filed the
Amendment to the Amended and Restated Certificate of Incorporation with the
state of Delaware. The Charter Amendment allows the Company to extend the date
by which the Company must (i) consummate a merger, capital stock exchange, asset
acquisition, stock purchase, reorganization or similar business combination
involving the Company and one or more businesses, which we refer to as a
"business combination," (ii) cease its operations if it fails to complete such
business combination, and (iii) redeem or repurchase 100% of the Company's Class
A Common Stock included as part of the units sold in the Company's initial
public offering that was consummated on December 29, 2021, which we refer to as
the "Offering" or the "IPO," from March 29, 2023 (the "Termination Date") to
December 29, 2023 or such earlier date as determined by the board of directors,
which we refer to as the "Extension," and such later date, the "Extended Date,"
provided that (i) the Sponsor (or its affiliates or permitted designees) will
deposit into the Trust Account the lesser of (x) $191,666 or (y) $0.0575 per
share for each public share that is not redeemed in connection with the Special
Meeting for each such one-month extension until December 29, 2023 unless the
closing of the Company's initial business combination shall have occurred (the
"Extension Payment") in exchange for a non-interest bearing, unsecured
promissory note payable upon consummation of a business combination and (ii) the
procedures relating to any such extension, as set forth in the Trust Agreement,
shall have been complied with. In connection with the approval of the Extension
Amendment Proposal and the Trust Amendment Proposal at the Shareholders Meeting,
holders of 5,289,280 of the Company's Class A Common Stock (the "Public Shares")
exercised their right to redeem those shares for cash at an approximate price of
$10.45 per share, for an aggregate of approximately $55,272,976 million.
Following the payment of the redemptions, the Trust Account has a balance of
approximately $50,668,688 million before the Extension Payment. On March 29,
2023 the Company caused to be deposited the Extension Payment into the Company's
Trust account for its public stockholders, representing $0.0378 per public
share, allowing the Company to extend the period of time it has to consummate
its initial business combination by one month from March 29, 2023 to April 29,
2023.
Proposed Business Combination
On April 25, 2022, the Company entered into an Agreement and Plan of Merger (the
"Merger Agreement"), by and among the Company, Arogo Merger Sub, Inc., a
Delaware corporation and wholly-owned subsidiary of the Company ("Merger Sub"),
EON Reality, Inc., a California corporation ("EON"), Koo Dom Investment, LLC, in
its capacity as the Company representative ("Arogo Representative"), and EON, in
its capacity as the seller representative ("Seller Representative"). On October
6, 2022, the parties to the Merger Agreement entered into that certain First
Amendment to the Agreement and Plan of Merger (the "Amendment"). The Business
Combination agreement and related agreements are further described in the
Company's Current Report on Form 8-K filed with the SEC on April 26, 2022, and
on October 7, 2022. We expect to continue to incur significant costs in the
pursuit of our acquisition plans. We cannot assure you that our plans to raise
capital or to complete the proposed Business Combination will be successful.
For further information regarding the Merger Agreement and our proposed initial
Business Combination with EON, please refer to Note 1 of this Annual Report and
the Company's Form S-4/A, which was filed with the SEC on October 7, 2022.
Registration Statement on Form S-4
The Company filed a Registration Statement on Form S-4 with the SEC on October
7, 2022, to register the issuance of the Company Common Stock that will be
issued at the consummation of the Business Combination, the warrants exercisable
for Company Common Stock that will result from the amendment of the Company's
public warrants at the consummation of the Business Combination and the Company
Common Stock issuable upon exercise of such warrants. The Company filed an
Amendment No. 1 thereto on February 13, 2023. We use the term "Arogo Form S-4"
to refer to the original registration statement as amended by the first
amendment and as it may be subsequently further amended.
25
Results of Operations
As of December 31, 2022, we have neither engaged in any operations nor generated
any revenues. All activity for the period from June 9, 2021 (inception) through
December 31, 2022, relates to our formation and the initial public offering. We
will not generate any operating revenues until after the completion of our
initial business combination, at the earliest. We will generate non-operating
income in the form of interest income on cash and cash equivalents from the
proceeds derived from the initial public offering.
For the period from June 9, 2021 (inception) through December 31, 2022, we had a
net loss of $731,053, which resulted entirely from formation and operating
costs.
Liquidity and Capital Resources
On December 29, 2021, we consummated our initial public offering of 10,350,000
units at a price of $10.00 per unit, at $10.00 per unit, generating gross
proceeds of $103.5 million. Simultaneously with the closing of our initial
public offering, we consummated the private placement of an aggregate of 466,150
Units to Koo Dom Investment LLC, at a price of $10.00 per Private Placement
Unit, generating total gross proceeds of $4,661,500.
For the period from June 9, 2021 (inception) through December 31, 2022, cash
used in operating activities was $1,157,002. Net loss of $731,053 was affected
by unrealized gain on marketable securities held in the Trust account of
$1,102,427. Changes in operating assets and liabilities used $1,157,002 of cash
for operating activities.
As of December 31, 2022, we had investments of $105,941,664 held in the Trust
Accounts. We intend to use substantially all of the funds held in the Trust
Accounts, including any amounts representing interest earned on the Trust
Accounts (less taxes paid and deferred underwriting commissions) to complete our
initial business combination. We may withdraw interest to pay taxes. During the
period ended December 31, 2022, we withdrew $213,263 interest earned on the
Trust Accounts. To the extent that our capital stock or debt is used, in whole
or in part, as consideration to complete our initial business combination, the
remaining proceeds held in the Trust Accounts will be used as working capital to
finance the operations of the target business or businesses, make other
acquisitions and pursue our growth strategies.
As of December 31, 2022, we had cash of $52,989 outside of the Trust Accounts.
We intend to use the funds held outside the Trust Accounts primarily to evaluate
target businesses, perform business due diligence on prospective target
businesses, travel to and from the offices, plants or similar locations of
prospective target businesses or their representatives or owners, review
corporate documents and material agreements of prospective target businesses,
and structure, negotiate and complete our initial business combination.
In order to fund working capital deficiencies or finance transaction costs in
connection with our initial business combination, our Sponsor or an affiliate of
our Sponsor or certain of our officers and directors may, but are not obligated
to, loan us funds as may be required. If we complete our initial business
combination, we would repay such loaned amounts. In the event that our initial
business combination does not close, we may use a portion of the working capital
held outside the Trust Accounts to repay such loaned amounts but no proceeds
from our Trust Accounts would be used for such repayment. Up to $1,500,000 of
such loans may be convertible into units, at a price of $10.00 per unit at the
option of the lender, upon consummation of our initial business combination. The
units would be identical to the placement units.
If our estimate of the costs of identifying a target business, undertaking
in-depth due diligence and negotiating a Business Combination are less than the
actual amount necessary to do so, we may have insufficient funds available to
operate our business prior to our Business Combination. Moreover, we may need to
obtain additional financing either to complete our Business Combination or
because we become obligated to redeem a significant number of our Public Shares
upon consummation of our Business Combination, in which case we may issue
additional securities or incur debt in connection with such Business
Combination.
In connection with our assessment of going concern considerations in accordance
with FASB ASU 2014-15, "Disclosures of Uncertainties about an Entity's ability
to Continue as a Going Concern," we have determined that if we are unable to
raise additional funds to alleviate liquidity needs as well as complete a
Business Combination by March 29, 2023, (or until December 29, 2023 if we choose
to extend) then we will cease all operations except for the purpose of
liquidating. The liquidity condition and the date for mandatory liquidation and
subsequent dissolution raises substantial doubt about our ability to continue as
a going concern. We plan to consummate a Business Combination prior to the
mandatory liquidation date. No adjustments have been made to the carrying
amounts of assets or liabilities should we be required to liquidate after March
29, 2023 (or December 29, 2023).
26
Extension Payment Deposit
On March 29, 2023, the Company caused to be deposited the Extension Payment into
the Company's Trust account for its public stockholders, representing $0.0378
per public share, allowing the Company to extend the period of time it has to
consummate its initial business combination by one month from March 29, 2023 to
April 29, 2023.
Critical Accounting Policies
The preparation of audited financial statements and related disclosures in
conformity with accounting principles generally accepted in the United States of
America requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities, disclosure of contingent assets and
liabilities at the date of the audited financial statements, and income and
expenses during the periods reported. Actual results could materially differ
from those estimates. As of December 31, 2022, there were no critical accounting
policies.
Net Loss Per Ordinary Share
Net income (loss) per share is computed by dividing net income (loss) by the
weighted average number of common stock shares outstanding for the period. The
calculation of diluted income (loss) per share does not consider the effect of
the warrants issued in connection with the Initial Public Offering and warrants
issued as components of the Private Placement Units (the "Placement Warrants")
since the exercise of the warrants are contingent upon the occurrence of future
events and the inclusion of such warrants would be anti-dilutive.
Net loss per share, basic and diluted, for Class A and Class B non-redeemable
common stock is calculated by dividing the net loss, adjusted for income
attributable to Class A redeemable common stock shares, by the weighted average
number of Class A and Class B non-redeemable common stock shares outstanding for
the period. Non-redeemable Class A and Class B common stock shares includes the
Founder Shares and non-redeemable common stock shares as these shares do not
have any redemption features and do not participate in the income earned on the
Trust Account. On December 31, 2022 and December 31, 2021, the Company did not
have any dilutive securities and other contracts that could, potentially, be
exercised or converted into shares of common stock and then share in the
earnings of the Company. As a result, diluted loss per share is the same as
basic loss per share for the periods presented.
Class A common stock subject to possible redemption
The Company accounts for its Class A common stock subject to possible redemption
in accordance with the guidance enumerated in ASC 480 "Distinguishing
Liabilities from Equity". Common stock subject to mandatory redemption are
classified as a liability instrument and are measured at fair value.
Conditionally redeemable common stock (including common stock that features
redemption rights that are either within the control of the holder or subject to
redemption upon the occurrence of uncertain events not solely within the
Company's control) is classified as temporary equity. At all other times, common
stock is classified as stockholders' equity. The Company's Class A common stock
features certain redemption rights that are considered by the Company to be
outside of the Company's control and subject to the occurrence of uncertain
future events. Accordingly, on December 31, 2022, the 10,350,000 shares of Class
A common stock subject to possible redemption in the amount of $105,052,500 is
presented as temporary equity, outside of the stockholders' deficit section of
the Company's balance sheet.
Derivative Financial Instruments
The Company evaluates its financial instruments to determine if such instruments
are derivatives or contain features that qualify as embedded derivatives in
accordance with ASC Topic 815, "Derivatives and Hedging". For derivative
financial instruments that are accounted for as liabilities, the derivative
instrument is initially recorded at its fair value on the grant date and is then
re-valued at each reporting date, with changes in the fair value reported in the
statements of operations. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as
equity, is evaluated at the end of each reporting period. Derivative liabilities
are classified in the balance sheet as current or non-current based on whether
or not net-cash settlement or conversion of the instrument could be required
within 12 months of the balance sheet date.
27
Recent Accounting Standards
In August 2020, the FASB issued ASU No. 2020-06, "Debt-Debt with Conversion and
Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in
Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments
and Contracts in an Entity's Own Equity" ("ASU 2020-06 "), which simplifies
accounting for convertible instruments by removing major separation models
required under current GAAP. ASU 2020-06 removes certain settlement conditions
that are required for equity contracts to qualify for the derivative scope
exception and it also simplifies the diluted earnings per share calculation in
certain areas. ASU 2020-06 is effective for fiscal years beginning after
December 15, 2023, including interim periods within those fiscal years, with
early adoption permitted. The Company is currently assessing the impact, if any,
that ASU 2020-06 would have on its financial position, results of operations or
cash flows. Management does not believe that any recently issued, but not yet
effective, accounting standards, if currently adopted, would have a material
effect on the Company's financial statements.
Off-Balance Sheet Arrangements
As of December 31, 2022, we did not have any off-balance sheet arrangements as
defined in Item 303(a)(4)(ii) of Regulation S-K.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease
obligations or long-term liabilities, other than an agreement to pay an
affiliate of our Sponsor a monthly fee of $10,000 for office space, utilities,
out of pocket expenses, and secretarial and administrative support. We began
incurring these fees on December 29, 2021 and will continue to incur these fees
monthly until the earlier of the completion of the business combination or our
liquidation.
The underwriters are entitled to a deferred fee of $3,622,500. The deferred fee
will become payable to the underwriters from the amounts held in the trust
account solely in the event that we complete a business combination, subject to
the terms of the underwriting agreement.
© Edgar Online, source Glimpses